Mettler-Toledo International (MTD) Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MTD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MTD, but not buy additional shares or sell existing shares.
View MTD analyst ratings or view top-rated stocks.

5 equities research analysts have issued twelve-month price targets for Mettler-Toledo International's shares. Their MTD share price forecasts range from $1,350.00 to $1,650.00. On average, they predict the company's share price to reach $1,470.14 in the next year. This suggests a possible upside of 31.2% from the stock's current price.
View analysts price targets for MTD or view top-rated stocks among Wall Street analysts.

Mettler-Toledo International's stock was trading at $1,445.45 at the beginning of 2023. Since then, MTD stock has decreased by 22.5% and is now trading at $1,120.74.
View the best growth stocks for 2023 here.

Mettler-Toledo International saw a increase in short interest in September. As of September 15th, there was short interest totaling 566,700 shares, an increase of 29.7% from the August 31st total of 436,900 shares. Based on an average daily volume of 152,500 shares, the short-interest ratio is presently 3.7 days. Currently, 2.6% of the company's stock are short sold.
View Mettler-Toledo International's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our MTD earnings forecast.

Mettler-Toledo International Inc. (NYSE:MTD) issued its quarterly earnings results on Thursday, July, 27th. The medical instruments supplier reported $10.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.99 by $0.20. The medical instruments supplier had revenue of $982.12 million for the quarter, compared to the consensus estimate of $1 billion. Mettler-Toledo International had a net margin of 22.48% and a negative trailing twelve-month return on equity of 2,136.23%.

ETFs with the largest weight of Mettler-Toledo International (NYSE:MTD) stock in their portfolio include Martin Currie Sustainable International Equity ETF (MCSE), First Trust NYSE Arca Biotechnology Index Fund (FBT), Invesco Focused Discovery Growth ETF (IVDG), iShares Biotechnology ETF (IBB), Logan Capital Broad Innovative Growth ETF (LCLG), Goldman Sachs Future Health Care Equity ETF (GDOC), Invesco Bloomberg MVP Multi-factor ETF (PWC) and Hennessy Stance ESG Large Cap ETF (STNC).

Mettler-Toledo International issued an update on its third quarter 2023 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $9.55-$9.85 for the period, compared to the consensus estimate of $11.42. The company issued revenue guidance of $946.41 million-$956.27 million, compared to the consensus revenue estimate of $1.04 billion.

224 employees have rated Mettler-Toledo International Chief Executive Officer Olivier A. Filliol on Glassdoor.com. Olivier A. Filliol has an approval rating of 88% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mettler-Toledo International investors own include Intuitive Surgical (ISRG), NVIDIA (NVDA), Home Depot (HD), Adobe (ADBE), AbbVie (ABBV), Johnson & Johnson (JNJ), Northrop Grumman (NOC), Alibaba Group (BABA), Lockheed Martin (LMT) and Broadcom (AVGO).

Mettler-Toledo International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTD."

Mettler-Toledo International's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.87%), State Street Corp (4.40%), WCM Investment Management LLC (4.21%), Capital International Investors (3.02%), Geode Capital Management LLC (2.35%) and Alliancebernstein L.P. (2.24%). Insiders that own company stock include Ann Ping Richard Wong, Christian Magloth, Elisha W Finney, Gerry Keller, La Guerroniere Marc De, Oliver A Filliol, Olivier A Filliol, Patrick Kaltenbach, Peter Aggersbjerg, Robert F Spoerry, Robert F Spoerry, Shawn Vadala, Thomas P Salice and Wah-Hui Chu.
View institutional ownership trends.

Shares of MTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MTD stock can currently be purchased for approximately $1,120.74.

Mettler-Toledo International (NYSE:MTD) has a market capitalization of $24.50 billion and generates $3.92 billion in revenue each year. The medical instruments supplier earns $872.50 million in net income (profit) each year or $39.78 on an earnings per share basis.

The company employs 18,000 workers across the globe.

Mettler-Toledo International's mailing address is 1900 POLARIS PARKWAY, COLUMBUS OH, 43240. The official website for the company is www.mt.com. The medical instruments supplier can be reached via phone at (614) 438-4511, via email at mary.finnegan@mt.com, or via fax at 614-438-4900.